Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve the Unaudited Financial Statements ....
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Sanofi India Ltd will meet on Thursday, 31st July 2025, to consider and approve the Unaudited Financial Results for the quarter and half-year ended 30th June 2025. This is a routine regulatory disclosure under SEBI listing regulations. The trading window for insiders has been closed from 1st July 2025 to 2nd August 2025 to prevent trading during the results announcement period. No financial figures or business details have been shared in this filing, as it is only an advance intimation of the board meeting.
This is a procedural announcement with no direct impact on shareholders. Investors should wait for the actual unaudited results to be released on or after 31st July 2025 to gauge Q1 FY26 performance. The stock may see trading activity only around the results announcement date.